Delivery Order SPE2DB20D1110-SPE2DB25FJ79M

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. federal government. The contract is a delivery order with a firm fixed price of $1,739.13 and an ultimate completion date of September 4, 2024. This award is not associated with a set-aside program....
This federal contract award is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $1,951.09 and an ultimate completion date of August 23, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not set aside for...
This federal contract award is for the delivery of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,803.37, is a delivery order placed under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen. The IDC,...
This federal contract award is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,496.52, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for the delivery of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,626.57, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablet medication to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,425.60. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract has a ceiling value of $2,343.40 and runs through November 29, 2024. This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide MICARDIS HCT 80-25 MG TABLET UD 30S. The contract is a delivery order with a firm fixed price of $2,761.11 and a completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a Firm Fixed Price Delivery Order with a ceiling value of $14,402.61 and a completion date of November 4, 2021. The contract was awarded on November 3, 2021 and there was no set-aside designation....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a ceiling value of $1,353.96 and a completion date of March 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FJ79M
    Delivery Order

The federal contract award is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $2,350.77 and a period of performance through November 27, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:14 PM